Regulation of Growth Factor-Induced Signaling by Protein-Tyrosine-Phosphatases

Experimental Biology and Medicine

Volumn 216, Issue 1, 1997, Pages 1-20

  Byon, John C H ^a   Kenner, Kathleen A ^c   Kusari, Anasua B ^a   Kusari, Jyotirmoy ^a,b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; GROWTH FACTOR; INSULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; CELL CULTURE; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME STRUCTURE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD45; GROWTH SUBSTANCES; HUMANS; INSULIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTEIN-TYROSINE-PHOSPHATASE; SHP1 PROTEIN TYROSINE PHOSPHATASE; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0030963867     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-216-44153     Document Type: Article

References (153)

1. Carpenter G, King L Jr., Cohen S. Rapid enhancement of protein phosphorylation in A-431 cell membrane preparations by epidermal-growth factor. J Biol Chem 254:5084-5091, 1979.
2. Tonks NK, Diltz CD, Fisher EH. Characterization of the major protein-tyrosine phosphatase of human placenta. J Biol Chem 263:6722-6730, 1988.
3. Charbonneau H, Tonks NK, Kumar S, Diltz CD, Harrylock M, Cool DE, Krebs EG, Fisher EH. Human placenta protein-lyrosine phosphatase: Amino-acid sequence and relationship to a family of receptor-like proteins. Proc Natl Acad Sci USA 86:5252-5256, 1989.
4. Guan K, Dixon JE. Protein tyrosine phosphatase activity of an essential virulence determinant in Yersinia. Science 249:553-556, 1990.
5. Tonks NK, Neel BG. From form to function: Signaling by protein tyrosine phosphatases. Cell 87:365-368, 1996.
6. Mauro LJ, Dixon JE. "Zip codes" direct intracellular protein tyrosine phosphatases to the correct cellular "address." Trends Biochem Sci 19:181-185, 1994.
7. Desai DM, Sap J, Schlessinger J, Weiss A. Ligand-mediated negative regulation of a chimeric transmembrane receptor tyrosine phosphatase. Cell 73:541-554, 1993.
8. McKenney DW, Onodera H, Gorman L, Mimura T, Rothstein DM. Distinct isoforms of the CD45 protein-tyrosine phosphatase differentially regulate interleukin-2 secretion and activation signal pathways involving Vav in T-cells. J Biol Chem 270:24949-24954, 1995.
9. Chui D, Ong CJ, Johnson P, Teh HS, Marth JD. Specific CD45 isoforms differentially regulate T-cell receptor signaling. EMBO J 13:798-807, 1994.
10. Fearon DT. The CD19-CR2-TAPA-I complex, CD45 and signaling by the antigen receptor of B-lymphocytes. Curr Opin Immunol 5:341-350, 1993.
11. Bajpai A, Brahmi Z. Target cell-induced inactivation of cytolytic lymphocytes. Role and regulation of CD45 and calyculin A inhibited phosphatase in response to interleukin-2. J Biol Chem 269:18864-18869, 1994.
12. Desai DM, Sap J, Silvennoinen O, Schlessinger J, Weiss A. The catalytic activity of the CD45 membrane-proximal phosphatase domain is required for TCR signaling and regulation EMBO J 13:4002-4010, 1994.
13. Yamada H, Kishihara K, Kong YY, Nomoto K. Enhanced generation of NK cells with intact cytotoxic function in CD45 exon 6 deficient mice. J Immunol 157:1523-1528, 1996.
14. Latinis M, Koretzsky GA. Fas ligation induces apoptosis and Jun kinase activation independently of CD45 and Lck in human T-cell. Blood 87:871-875, 1996.
15. Byth KF, Conroy LA, Hewlett S, Smith AJ, May J, Alexander DR, Holmes N. CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development in the selection of CD4+CD8+ thymocytes and B-cell maturation. J Exp Med 183:1707-1718, 1996.
16. Loh RK, Jabara HH, Ren CL, Fu SM, Vercelli D, Geha RS. Role of protein tyrosine phosphatases in isotype switching: Cross-linking CD45 to CD40 inhibits IgE isotype switching in human B-cells. Immunol Lett 45:99-106, 1995.
17. Kolb JP, Abadie A. Inhibitors of protein tyrosine kinases and protein tyrosine phosphatases suppress IL-4 induced CD23 expression and release by human B-lymphocytes. Eur Cytokine Netw 4:429-438, 1993.
18. Corvaia N, Reischl IG, Kroemer E, Mudde GC. Modulation of Fc-γ receptor-mediated early events by the tyrosine phosphatase CD45 in primary human monocytes. Consequences for interleukin-6 production. Eur J Immunol 25:738-744, 1995.
19. Shivman E, Clayton L, Allridge L, Seating KE, Gullberg M, Alexander DR. CD45 monoclonal antibodies inhibit TCR-mediated calcium signals, calmodulin kinase IV/Gr activation, and oncoprotein 18 phosphorylation. J Immunol 157:101-109, 1996.
20. Mooney RA, Freund GG, Way BA, Bordwell KL. Expression of a transmembrane phosphotyrosine phosphatase inhibits cellular response to platelet-derived growth factor and insulin-like growth factor-1. J Biol Chem 267:23443-23450, 1992.
21. Way BA, Mooney RA. Activation of phosphatidylinositol-3-kinase by platelet-derived growth factor and insulin-like growth factor-1 is inhibited by a transmembrane phosphotyrosine phosphatase. J Biol Chem 268:26409-26415, 1993.
22. Way BA, Mooney RA. Differential effects of phosphotyrosine phosphatase expression on hormone-dependent and independent pp60-src activity. Mol Cell Biol 139:167-175, 1994.
23. Kulas DT, Freund GG, Mooney RA. The transmembrane protein-phosphatase CD45 is associated with decreased insulin receptor signaling. J Biol Chem 271:755-760, 1996.
24. Streuli M, Krueger NX, Hall CR, Schlossman SM, Saito H. A new member of the immunoglobin super-family that has a cytoplasmic region homologous to the leukocyte common antigen. J Exp Med 168:1523-1530, 1988.
25. Walton KM, Dixon JE. Protein tyrosine phosphatases. In: Richardson CC, Abelson JN, Meister A, Walsh CT, Eds. Annual Review of Biochemistry. Palo Alto: Annual Review, Vol 62:pp101-120, 1993.
26. Zhang JS, Longo FM. LAR tyrosine phosphatase receptor: alternative splicing is preferential to the nervous system, coordinated with cell growth and generates novel isoforms containing extensive CAG repeats. J Cell Biol 128:415-431, 1995.
27. Longo FM, Martignetti JA, Le Beau JM, Zhang JS, Barnes JP, Brosius J. Leukocyte common antigen-related receptor-linked phosphatase. Regulation of mRNA expression. J Biol Chem 268:26503-26511, 1993.
28. Zhang WR, Hashimoto N, Ahmad F, Ding W, Goldstein BJ. Molecular cloning and expression of a unique receptor-like protein-tyrosine phosphatase in the leukocyte-common-antigen-related phosphatase family. Biochem J 302:39-49, 1994.
29. Ahmad F, Goldstein BJ. Purification, identification and subcellular distribution of three prominent protein-tyrosine phosphatase enzymes in skeletal muscle tissue. Biochem Biophys Res Commun 1250:57-69, 1995.
30. Ding W, Zhang WR, Sullivan K, Hashimoto N, Goldstein BJ. Identification of protein-tyrosine phosphatases prevalent in adipocytes by molecular cloning. Biochem Biophys Res Commun 202:902-907, 1994.
31. Hashimoto N, Feener EF, Zhang WR, Goldstein BJ. Insulin receptor protein-tyrosine phosphatases. Leukocyte-common-antigen-related phosphatase rapidly deactivates in insulin receptor kinase by preferential dephosphorylation of the receptor regulatory domain. J Biol Chem 267:13811-13814, 1992.
32. Kulas DT, Goldstein BJ, Mooney RA. The transmembrane protein-tyrosine phosphatase LAR modulates signaling by multiple receptor tyrosine kinases. J Biol Chem 271:750-754, 1996.
33. Feng GS, Hui CC, Pawson T. SH2-containing phosphotyrosine phosphatases as a target of protein-tyrosine kinases. Science 259:1607-1611, 1993.
34. Vogel W, Lammers R, Huang S, Ullrich A. Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. Science 259:1611-1614, 1993.
35. Ahmad S, Banville D, Zhao Z, Fisher EH, Shen SH. A widely expressed human protein-tyrosine phosphatase containing two src homology 2 domains. Proc Natl Acad Sci USA 90:2197-2201, 1993.
36. Adachi M, Sekiya M, Miyachi T, Matsuno K, Hiroda Y, Imai K, Yachi A. Molecular cloning and sequencing of a novel protein-tyrosine phosphatase SH-PTP3 with sequence similarity to the srchomology 2 region. FEBS Lett 314:335-339, 1993.
37. Matozaki T, Suzuki T, Uchida T, Inazawa J, Ariyama T, Matsuda K, Horita K, Noguchi M, Mizuno H, Sakamoto C, Kasuga M. Molecular cloning of a human transmembrane-lype prolein-tyrosine phosphatase and its expression in gastrointestinal cancers. J Biol Chem 269:2075-2081, 1994.
38. Lechleider RJ, Freeman RM Jr., Neel BG. Tyrosyl phosphorylation and growth factor receptor association of the human corkscrew homologue SHP-2. J Biol Chem 268:13434-13438, 1993.
39. Kazlauskas A, Feng GS, Pawson T, Valius M. The 64-κDa protein that associates with the platelet-derived growth factor receptor β subunit via Tyr-1009 is the SH2-containing phosphotyrosine phosphatase Syp. Proc Natl Acad Sci USA 90:6939-6942, 1993.
40. Tauchi T, Feng GS, Shen R, Hoatlin M, Bagby GC Jr., Kabat D, Lu L, Broxmeyer HE. Involvement of SH2 containing phosphotyrosine phosphatase Syp in erythropoietin signal transduction pathways. J Biol Chem 270:5631-5635, 1995.
41. Seely BL, Reichart DR, Staubs PA, Jhun BH, Hsu D, Maegwa H, Milarski KL, Saltiel AR, Olefsky JM. Localization of the insulin-like growth factor-I receptor binding sites for the SH2 domain proteins p85, Syp, and GTPase activation protein. J Biol Chem 270:19151-19517, 1995.
42. Yamauchi K, Milarski KL, Saltiel AR, Pessin JE. Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin down-stream signaling. Proc Natl Acad Sci USA 92:664-668, 1995.
43. Welham MJ, Dechert U, Leslie KB, Jirik F, Schroeder JW. Interleukin (IL)-3 and granulocyte/macrophage colony stimulating factor, but not IL-4, induce tyrosine phosphorylation. activation, and association of SHP-2 with Grb2 and phosphatidylinositol 3′-kinase. J Biol Chem 269:23764-23768, 1994.
44. Fuhrer DK, Feng GS, Yang YC. Syp associates with gp 130 and Janus kinase 2 in response to interleukin-11 in 3T3-L1 mouse adipocytes. J Biol Chem 270:25026-25030, 1995.
45. Sugimoto S, Wandless TJ, Shoelson SE, Neel BG, Walsh CT. Activation of the SH2-containing protein tyrosine phosphatase, SHP-2, by phosphotyrosine-containing peptides derived from insulin receptor substrate-1. J Biol Chem 269:13614-13622, 1994.
46. Lechleider RJ, Sugimoto S, Bennett AM, Kashishian AS, Cooper JA, Shoelson SE, Walsh CT, Neel BG. Activation of the SH2-containing phosphotyrosine phosphatase SHP-2 by its binding site, phosphotyrosine 1009, in the human platelet-derived growth factor receptor p. J Biol Chem 268:21498-21501, 1993.
47. Kuhne MR, Pawson T, Lienhard GE, Feng GS. The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. J Biol Chem 268:11499-11501, 1993.
48. Keegan K, Cooper JA. Use of the two hybrid system to detect the association of the protein-tyrosine-phosphatase SHPTP2 with another SH2-containing protein Grb7. Oncogene 12:1537-1544, 1996.
49. Yamauchi K, Pessin JE. Epidermal growth factor-induced association of the SHPTP2 protein tyrosine phosphatase with a 115-kDa phosphotyrosine protein. J Biol Chem 270:15071-15074, 1995.
50. Kuhne MR, Shao Z, Rowles J, Lavan BE, Shen SH, Fisher EH, Lienhard GE. Dephosphorylation of insulin receptor substrate 1 by the tyrosine phosphatase PTP2C. J Biol Chem 269:15833-15837, 1994.
51. Case RD, Piccione E, Wolf G, Bennett AM, Lechleider RJ, Neel BG, Shoelson SE. SHP-2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor β-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides. J Biol Chem 269:10507-10494, 1994.
52. Reeves SA, Sinha B, Baur I, Reinhold D, Harsh G. An alternative role for the src-homology-domain-containing phosphotyrosine phosphatase (SHP-2) in regulating epidermal-growth factor dependent cell growth. Eur J Biochem 233:55-61, 1995.
53. Marengere LE, Waterhouse P, Duncan GS, Mittrucker HW, Feng GS, Mak TW. Regulation of T-cell receptor signaling by tyrosine phosphatase Syp association with CTLA-4. Science 272:1170-1173, 1996.
54. Cossette LJ, Hoglinger O, Mou L, Shen SH. Localization and down-regulation of the protein tyrosine phosphatase PTP2C in membrane ruffles of PDGF-stimulated cells. Exp Cell Res 223:459-506, 1996.
55. Tauchi T, Feng GS, Shen R, Song HY, Donner D, Pawson T. Broxmeyer HE. SH2-containing phosphotyrosine phosphatase Syp is a target of p210bcr-abl tyrosine kinase. J Biol Chem 269:15381-15387, 1994.
56. Li W, Nishimura R, Kashishian A, Batzer AC, Kirn WJH, Cooper JA, Schlessinger J. A new function for a phosphotyrosine phosphatase: Linking Grb2-Sos to a receptor tyrosine kinase. Mol Cell Biol 14:509-517, 1994.
57. Bennett AM, Tang TL, Sugimoto S, Walsh CT, Neel BG. Protein-lyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor β to Ras. Proc Natl Acad Sci USA 91:7335-7339, 1994.
58. Tanaka S, Ito T, Wands JR. Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signaling molecules. J Biol Chem 271:15010-15016, 1996.
59. Tauchi T, Feng GS, Marshall MS, Shen R, Mantel C, Pawson T, Broxmeyer HE. The ubiquitously expressed Syp phosphatase interacts with c-kit and Grb2 in hematopoietic cells. J Biol Chem 269:25206-25211, 1994.
60. Huang L, Turck CW, Rao P, Peters KG. Grb2 and SHP-2: Potentially important endothelial signaling molecules downstream of the TEK/ TIE2 receptor tyrosine kinase. Oncogene 11:2097-2103, 1995.
61. Bennett AM, Housdorff SF, O'Reilly AM, Freeman AM, Neel BG. Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression. Mol Cell Biol 16:1189-1202, 1996.
62. ras. Biochem Biophys Res Commun 214:737-743, 1995.
63. Perrimon N. The torso receptor protein-tyrosine kinase signaling pathway: An endless story. Cell 74:219-222, 1993.
64. Cleghon V, Gayko U, Copeland TD, Perkinas LA, Perrimon N, Morrison DK. Drosophila terminal structure development is regulated by the compensatory activities of positive and negative phosphotyrosine signaling sites on the torso RTK. Genes Dev 10:566-577, 1996.
65. Allard JD, Chang HC, Herbst R, McNeill H, Simon MA. The SH2-containing tyrosine phosphatase corkscrew is required during signaling by sevenless. Ras-1 and Raf. Development 122:1137-1150, 1996.
66. Herbst R, Carroll PM, Allard JD, Schilling J, Rabbe T, Simon MA. Daughter of sevenless is a substrate of the phospholyrosine phosphatase corkscrew and functions during sevenless signaling. Cell 85:899-909, 1996.
67. Rivard N, McKenzie FR, Brondello JM, Pouyssegur J. The phosphotyrosine phosphatase PTP1D, but not SHP-1, is an essential mediator of fibroblast proliferation induced by tyrosine kinase and G protein-coupled receptors. J Biol Chem 270:11017-11024, 1995.
68. Xiao S, Rose DW, Sasaoka T, Maegawa H, Burke TR Jr., Roller PP, Shoelson SE, Olefsky JM. Syp (SHP-2) is a positive mediator of growth-factor-stimulated mitogenic signal transduction. J Biol Chem 269:21244-21250, 1994.
69. Hausdorff SF, Bennett AM, Neel BG, Birnbaum MJ. Different signaling roles of SHPTP2 in insulin-induced GLUT1 expression and GLUT4 translocation. J Biol Chem 270:12965-12968, 1995.
70. Yi T, Cleveland JL, Ihle JN. Protein-tyrosine phosphatase containing SH2 domains: Characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13. Mol Cell Biol 12:836-850, 1992.
71. Matthews RJ, Bowne DB, Flores E, Thomas ML. Characterization of hematopoietic intracellular protein-tyrosine phosphatases: Description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Mol Cell Biol 12:2396-2405, 1992.
72. Plutzky J, Neel BG, Rosenberg RD. Isolation of a Src homology 2-containing tyrosine phosphatase. Proc Natl Acad Sci USA 89:1123-1127, 1992.
73. Shultz LD, Schweitzer PA, Rojan TV, Yi T, Ihle JN, Matthews RJ, Beier DR. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73:1445-1454, 1993.
74. Tsui HW, Siminovitch KA, de Souza L, Tsui FWL. Motheaten and viable mice have mutations in the hematopoietic cell phosphatase gene. Nat Genet 4:124-129, 1993.
75. Yeung YG, Berg KL, Pixley FJ, Angeletti RH, Stanley ER. Protein tyrosine phosphatase-1C is rapidly phosphorylated in tyrosine in macrophages in response to colony stimulating factor-1. J Biol Chem 267:23449-23450, 1992.
76. Chen HE, Chang S, Trub T, Neel BG. Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 16:3685-3697, 1996.
77. Pani G, Kozlowski M, Gambier JC, Mills GB, Siminovitch KA. Identification of the tyrosine phosphatase SHP-1 as a B-cell antigen receptor-associated protein involved in the regulation of B-cell signaling. J Exp Med 181:2077-2084, 1995.
78. D'Ambriosio D, Hippen KL, Minskoff SA, Mellman I, Pani G, Siminovitch KA, Gambier JC. Recruitment and activation of SHP-1 in negative regulation of antigen receptor signaling by Fc-γ RIIB1. Science 268:293-297, 1995.
79. Larner AC, David M, Feldman GM, Igarashi K, Hackelt RH, Webb DAS, Sweitzer SM, Petricoin EF III, Finbloom DS. Tyrosine phosphorylation of DNA binding proteins by multiple cytokines. Science 261:1730-1733, 1993.
80. Lamer AC, Finbloom AC. Protein tyrosine phosphorylation as a mechanism which regulates cytokine activation of early response genes. Biochim Biophys Acta 1266:278-287, 1995.
81. Ihle JN, Whitthuhn BA, Quelle FW, Yamamato K, Thierfelder WE, Kreider B, Silvennoinen O. Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem Sci 19:222-227, 1994.
82. Yetter A, Uddin S, Krolewski JJ, Jiao H, Yi T, Platanias LC. Association of the interferon-dependenl tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase. J Biol Chem 270:18179-18182, 1995.
83. David M, Chen HE, Goelz S, Lamer AC, Neel BG. Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 15:7050-7058, 1995.
84. Secrist JP, Bums LA, Karnitz L, Loretzky GA, Abraham RT. Stimulatory effects of the protein tyrosine inhibitor, pervanadate, on T-cell activation events. J Biol Chem 208:5886-5893, 1993.
85. MiuraO, D'Andrea A, Kabat D, Ihle JN. Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis. Mol Cell Biol 11:5095-4902, 1991.
86. Tohda S, Nara N, Imai Y, Aoki N. Effect of protein kinase inhibitors on the proliferation of leukemic cells stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony stimulating factor or interleukin-3. Leukemia 5:813-814, 1991.
87. Yi T, Mui ALF, (Crystal G, Ihle JN. Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor β chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis. Mol Cell Biol 13:7577-7586, 1993.
88. Paulson RF, Vesely S, Siminovitch KA, Bernstein A. Signaling by the W/kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shpl. Nat Genet 13:309-315, 1996.
89. Yi T, Ihle JN. Association of hematopoietic cell phosphatase with c-Kit after stimulation with c-Kit ligand. Mol Cell Biol 13:3350-3358, 1993.
90. Plas DR, Johnson R, Pingel JT, Matthews RJ, Dalton M, Roy G, Chan AC, Thomas ML. Direct regulation of ZAP-70 by SHP-1 in T-cell antigen receptor signaling. Science 272:1173-1176, 1996.
91. Linnekan D, Evans GA, D'Andrea A, Farrar WL. Association of the erythropoietin receptor with protein tyrosine kinase activity. Proc Natl Acad Sci USA 89:6237-6241, 1992.
92. Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O, Ihle JN. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227-236, 1993.
93. Klingmuller U, Lorenz U, Cantley LC, Neel BG, Lodish HF. Specific recruitment of SHP-1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80:729-738, 1995.
94. Uchida T, Matozaki T, Noguchi T, Yamato T, Horita K, Suzuki T, Fujiyoka Y, Sakamoto C, Kasuga M. Insulin stimulates the phosphorylation of Tyr538 and the catalytic activity of SHP-1, a protein tyrosine phosphatase with Src homology-2 domains. J Biol Chem 269:12220-12228, 1994.
95. Vambutas V, Kaplan DR, Sells MA, Chernoff J. Nerve growth factor stimulates tyrosine phosphorylation and activation of Src homology-containing protein-tyrosine phosphatase 1 in PC12 cells. J Biol Chem 270:25629-25633, 1995.
96. Semiya H, Sawabe T, Toho M, Tsuruo T. Phorbol ester-resistant monoblastoid leukemia cells with a functional mitogen-activated protein kinase cascade but without responsive protein tyrosine phosphatases. Oncogene 11:2049-2054, 1995.
97. Zhao Z, Shen S-H, Fischer EH. Phorbol ester-induced expression, phosphorylation, and translocation of protein-tyrosine-phosphatase 1C in HL-60 cells. Proc Natl Acad Sci USA 91:5007-5011, 1994.
98. Guan K, Boyles SS, Dixon JE. A Tyr/Ser phosphatase encoded by vaccinia virus. Nature 350:359-362, 1991.
99. Coleman TR, Dunphy WG. Cdc2 regulatory factors. Curr Opin Cell Biol 6:877-882, 1994.
100. Sebastian B, Kakizuka A, Hunter T. Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15. Proc Natl Acad Sci USA 90:3521-3524, 1993.
101. Keyse SM, Emslie EA. Oxidative stress and heat shock induce a human gene encoding a protein lyrosine phosphatase. Nature 359:644-649, 1992.
102. Charles CH, Sun H, Lau LF, Tonks NK. The growth factor inducible immediate-early gene 3CH134 encodes a protein-lyrosine phosphatase. Proc Natl Acad Sci USA 90:5292-5296, 1993.
103. Noguchi T, Metz R, Chen L, Mattel M-G, Carrasco D, Bravo R. Structure, mapping, and expression of erp, a growth-factor inducible gene encoding a nontransmembrane protein tyrosine phosphatase, and effect of ERP on cell growth. Mol Cell Biol 13:5195-5205, 1993.
104. Zhang CF, Guan KL. Dephosphorylation and inactivation of the mitogen-activated protein kinase by a mitogen-inducible Thr/Tyr protein phosphatase. J Biol Chem 268:16116-16119, 1993.
105. Sun H, Charles CH, Lau LF, Tonks NK. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75:493-507, 1993.
106. 105a. Kusari AB, Byon J, Bandyopadhyay D, Kenner KA, Kusari J. Insulin-induced mitogen-activated protein (MAP) kinase phosphatase-1 (MKP-1) attenuates insulin-stimulated MAP kinase activity: A mechanism for the feedback inhibition of insulin signaling. Mol Endocrinol 11:1532-1543, 1997.
107. Rutter GA, White MR, Tavare JM. Involvement of MAP kinase in insulin signaling revealed by non-invasive imaging of luciferase gene expression in single living cells. Curr Biol 5:890-899, 1995.
108. Duff JL, Monia BR, Berk BC. Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. Effect of actinomycin D and antisense oligonucleotides. J Biol Chem 270:7161-7166, 1995.
109. 2 receptors on the developing rat fetus. J Clin Invest 88:921-933, 1991.
110. Chiu AT, Herblin WF, McCall DE, Ardecky RJ, Carini DJ, Duncia JV, Pease LJ, Wong PL, Wexler RR, Johnson AL, Timmermans PB. Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun 165:196-203, 1989.
111. Millan MA, Jacobwitz DM, Aguilera G, Catt KJ. Differential distribution of AT1 and AT2 angiotensin II receptor subtypes in the rat brain during development. Proc Natl Acad Sci USA 88:11440-11444, 1991.
112. Pucell AG, Hodges JC, Sen I, Bumpus FM, Husain A. Biochemical properties of the ovarian granulosa cell type 2-angiotensin II receptor. Endocrinology 128:1949-1959, 1991.
113. Speth RC, Kim KH. Discrimination of two angiotensin II receptor subtypes with a selective agoinst analogue of angiotensin II, p-aminophenylanine-6-angiotensin II. Biochem Biophys Res Commun 169:997-1006, 1990.
114. Dudley DT, Summerfeit RM. Regulated expression of angiotensin II (AT2) binding sites in R3T3 cells. Regul Pept 44:199-206, 1993.
115. Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA 93:156-160, 1996.
116. Liu Y, Gorospe M, Holbrook NJ. Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. Inhibition of c-Jun N-terminal kinase activity and AP-1 dependent gene activation. J Biol Chem 270:8377-8380, 1995.
117. Cornelius G, Engel M. Stress causes induction of MAP kinase-specific phosphatase and rapid repression of MAP kinase activity in Drosophila. Cell Signal 7:611-615, 1995.
118. Alessi D, Smythe C, Keyse SM. The human CL100 gene encodes a Tyr/Thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts. Oncogene 8:2015-2020, 1993.
119. Sun H, Tonks NK, Bar-Sagi D. Inhibition of Ras-induced DNA synthesis by expression of the phosphatase MKP-1. Science 266:285-288, 1994.
120. Brondello JM, McKenzie FR, Sun H, Tonks NK, Pouyssegur J. Constitutive MAP kinase phosphatase (MKP-1) expression blocks G1 specific gene transcription and S-phase entry in fibroblasts. Oncogene 10:1895-1904, 1995.
121. Sugimoto T, Haneda M, Togawa M, Isono M, Shikano T. Araki S, Nakagawa T, Kashiwagi A, Guan KC, Kikkawa R. Atrial-natriuretic peptide induces the expression of MKP-1, a mitogen-activated kinase protein kinase phosphatase, in glomerular mesangial cells. J Biol Chem 271:544-549, 1996.
122. Krautwald S, Buscher D, Dent P, Ruthenberg K, Baccarini M. Suppression of growth factor-mediated MAP kinase activation by v-raf in macrophages: A putative role for the MKP-1 phosphatase. Oncogene 10:1187-1192, 1995.
123. Bokemeyer D, Sorokin A, Van M, Ahn NG, Templeton Dl, Dunn MJ. Induction of mitogen-activated protein kinase phosphatase 1 by the stress-activated protein kinase pathway but not by extracellular signal-regulated kinase in fibroblasts, J Biol Chem 271:639-642, 1996.
124. Dorfman K, Carrasco D, Gruda M, Ryan C, Lira SA, Bravo R. Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts. Oncogene 13:925-931, 1996.
125. Lewis T, Groom LA, Sneddon AA, Smythe C, Keyse SM. XCL100, and inducible nuclear MAP kinase phosphatase from Xenopus laevis: its role in MAP kinase inactivation in differentiated cells and its expression during early development. J Cell Sci 108(Pt 8):2885-2896, 1995.
126. Mistra-Press A, Rim CS, Yao H, Robertson MS, Stork PJ. A novel mitogen-activated protein kinase phosphatase. J Biol Chem 270:14587-14596, 1995.
127. Muda M, Beschert U, Kickinson R, Martinou JC, Martinou I, Camps M, Schlegel W, Arkinstall S. MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase. J Biol Chem 271:4319-4326, 1996.
128. Rohan PJ, Davis P, Moskaluk CA, Kearns M, Krutzsch H, Siebenlist U, Kelly K. PAC-1: A mitogen-induced nuclear protein tyrosine phosphatase. Science 259:1763-1766, 1993.
129. Ward Y, Gupta S, Jensen P, Wartmann M, Davis RJ, Kelly K. Control of MAP kinase activation by the mitogen-induced threonine/ tyrosine phosphatase PAC-1. Nature 367:651-654, 1994.
130. Chu Y, Solski PA, Khosravi-Far R, Der CJ, Kelly K. The mitogen-activated protein kinase phosphatases PAC-1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J Biol Chem 271:6497-6591, 1996.
131. Brunner D, Oellers N, Szabad J, Riggs WH, Zipursky SL, Hafen E. A gain of function mutation in Drosophila MAP kinase activates multiple receptor tyrosine kinase signaling pathways. Cell 76:875-888, 1994.
132. Bott CM, Thorneycroft SG, Marshall CJ. The sevenmaker gain-of-function mutation in p42 MAP kinase leads to enhanced signaling and reduced sensitivity to dual specificity phosphatase action. FEBS Lett 352:201-205, 1994.
133. Groom LA, Sneddon AA, Alessi DR, Dowd S, Keyse SM. Differential regulation of the MAP, SAP and RK/p38 kinases by Pystl, a novel cytosolic dual-specificity phosphatase. EMBO J 15:3621-3632, 1996.
134. Guan KL, Butch E. Isolation and characterization of a novel dual specific phosphatase HVH2, which selectively dephosphorylates the mitogen-activated protein kinase. J Biol Chem 270:7197-7203, 1995
135. Brown-Shimer S, Johnson KA, Hill DE, Bruskin AM. Effect of protein tyrosine phosphatase IB expression on transformation by the human neu oncogene. Cancer Res 52:498-502, 1992.
136. Hashimoto N, Goldstein BJ. Differential regulation of mRNAs encoding three protein-tyrosine phosphatases by insulin and activation of protein kinase C. Biochem Biophys Res Commun 188:1305-1311, 1992.
137. Cicirelli MF, Tonks NK, Diltz CD, Weiel JE, Fisher EH, Krebs EG. Microinjection of a protein-tyrosine phosphatase inhibits insulin action in Xenopus oocytes. Proc Natl Acad Sci USA 87:5514-5518, 1990.
138. Tonks NK, Cicirelli MF, Diltz CD, Krebs EG, Fisher EH. Effect of microinjection of a low Mr-human placental protein tyrosine phosphatase on induction of meiotic cell division in Xenopus oocytes. Mol Cell Biol 10:458-503, 1990.
139. Kenner KA, Hill DE, Olefsky JM, Kusari J. Regulation of protein tyrosine phosphatases by insulin and insulin-like growth factor I. J Biol Chem 268:25455-25502, 1993.
140. Kenner KA, Anyanwu E, Olefsky JM, Kusari J. Protein-tyrosine phosphatase IB is a negative regulator of insulin and insulin-like growth factor-I-stimulated signaling. J Biol Chem 271:19810-19816, 1996.
141. Ahmad F, Li PM, Meyerovitch J, Goldstein BJ. Osmotic loading of neutralizing antibodies demonstrates a role for protein tyrosine phosphatase IB in negative regulation of the insulin action pathway. J Biol Chem 270:20503-20508, 1996.
142. Liotta AS, Kole HK, Fales HM, Roth J, Bernier M. A synthetic tris-sulfotyrosyl dodecapeptide analogue of the insulin receptor 1150-kinase domain inhibits tyrosine dephosphorylation of the insulin receptor in situ. J Biol Chem 269:22996-23001, 1994.
143. Guan KL, Dixon JE. Evidence for protein-tyrosine phosphatase catalysis proceeding via a cysteine-phosphate intermediate. J Biol Chem 266:17026-17030, 1991.
144. Seely BL, Staubs PA, Reichart DR, Berhanu P, Milarski KL, Saltiel AR, Kusari J, Olefsky JM. Protein tyrosine phosphatase IB interacts with the activated insulin receptor. Diabetes 45:1379-1385, 1996.
145. Bandyopadhyay D, Kusari A, Kenner KA, Liu F, Chernoff J, Gustafson TA, Kusari J. Protein tyrosine phosphatase IB complexes with the insulin receptor in vivo and is tyrosine phosphorylated in the presence of insulin. J Biol Chem 272:1639-1645, 1997.
146. Pearson RB, Kemp BE. Design and use of peptide substrates for protein kinases. In: Hunter T, Setton BM, Eds. Methods in Enzymology. New York: Academic Press, Vol Part A 200:pp62-81, 1991.
147. Koch CA, Anderson D, Moran MF, Ellis C, Pawson T. SH2 and SH3 domains: Elements that control interactions of cytoplasmic signaling proteins. Science 252:668-674, 1991.
148. Mayer BJ, Jackson PK, Van Etten RA, Baltimore D. Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo. Mol Cell Biol 12:609-618, 1992.
149. Frangioni JV, Beahm PH, Shifrin V, Jost CA, Neel BG. The non-transmembrane tyrosine phosphatase FTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence. Cell 68:545-560, 1992.
150. Maegawa H, Ide R, Hasegawa M, Ugi S, Egawa D, Iwanishi M, Kikkawa R, Shigeta Y, Kashiwagi A. Thiazolidine derivatives ameliorate high glucose-induced insulin resistance via the normalization of protein-tyrosine phosphatase activities. J Biol Chem 270:7724-7730, 1995.
151. Faure R, Baquiran G, Bergeron JJ, Posner BI. The dephosphorylation of the insulin and epidermal growth factor receptors. Role of endosomc-associated phosphotyrosine phosphatases. J Biol Chem 267:11215-11221, 1992.
152. Burgess JW, Wada I, Ling N, Khan MN, Bergeron JJ. Posner BI. Decrease in beta-subunit phosphotyrosine correlates with internalization and activation of the endosomal insulin receptor kinase. J Biol Chem 267:10077-10086, 1992.
153. Hunter T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80:225-236, 1995.